Rankings
▼
Calendar
FDMT Q4 2018 Earnings — 4D Molecular Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FDMT
4D Molecular Therapeutics, Inc.
$427M
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$5M
Gross Profit
-$546,500
-12.1% margin
Operating Income
-$3M
-55.9% margin
Net Income
-$2M
-48.2% margin
EPS (Diluted)
$-0.43
QoQ Revenue Growth
+0.0%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$487,000
Balance Sheet
Total Assets
$97M
Total Liabilities
$125M
Stockholders' Equity
-$28M
Cash & Equivalents
$92M
← FY 2018
All Quarters
Q1 2019 →
